bioRxiv / medRxiv
open access
CC BY-NC 4.0
Use of systemic menopausal hormone therapy among French women: a descriptive nationwide study over the 2011 to 2024 period
BackgroundWorldwide use of systemic menopausal hormone therapy (MHT) declined sharply after 2002 following reports of increased breast cancer and cardiovascular risks. Evidence that the benefit-risk balance depends on initiation timing and treatment patterns has renewed clinical interest in MHT rece
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effects of EstroSense®/MD vs Placebo in Improving the Estrogen Profile in Females#1007734
- Relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis#4568
- Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer#849528
- Hormone Therapy Use and Risk of Chronic Disease in the Nurses’ Health Study: A Comparative Analysis With the Women's Health Initiative#384117
- CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL#1033425
Record · ID 1242662
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive